Is oocyte maturation rate associated with the dose of triptorelin used for triggering final oocyte maturation in high-risk for severe OHSS patients, undergoing ovarian stimulation.

被引：0

作者：

Lainas, T. G. ^{[1
]}

Lainas, G. ^{[1
]}

Sfontouris, I. ^{[1
]}

Venetis, C. ^{[2
]}

Bosdou, J. ^{[3
]}

Chatzimeletiou, A. ^{[3
]}

Tarlatzis, B. ^{[3
]}

Grimbizis, G. ^{[3
]}

Kolibianakis, E. ^{[3
]}

机构：

[1] Eugonia, Unit Assisted Reprod, Athens, Greece

[2] Univ New South Wales, Sch Womens & Childrens Hlth, UNSW Med, Sydney, NSW, Australia

[3] Aristotle Univ Thessaloniki, Sch Med, Human Reprod Unit, Dept Obstet & Gynecol 1, Thessaloniki, Greece

来源：

HUMAN REPRODUCTION | 2019年 / 34卷

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

P-606

引用

页码：419 / 420

页数：2

共 50 条

[1] Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome?
Lainas, G. T.
Lainas, T. G.
Sfontouris, I. A.
Chatzimeletiou, K.
Venetis, C. A.
Bosdou, J. K.
Tarlatzis, B. C.
Grimbizis, G. F.
Kolibianakis, E. M.
HUMAN REPRODUCTION, 2019, 34 (09) : 1770 - 1777
[2] The optimal dose of triptorelin for triggering final oocyte maturation in patients at high-risk for OHSS: a randomized clinical trial
Lainas, G. T.
Bosdou, J. K.
Venetis, C. A.
Sfontouris, I. A.
Chatzimeletiou, K.
Zepiridis, L.
Makedos, A.
Daniilidis, A.
Mitsoli, A.
Savvaidou, D.
Lainas, T. G.
Tarlatzis, B. C.
Kolibianakis, E. M.
HUMAN REPRODUCTION, 2015, 30 : 95 - 96
[3] BMI is not associated with oocyte recovery rate or maturation rate in high-risk for severe OHSS patients triggered with GnRH-agonist for final oocyte maturation
Sfontouris, I.
Lainas, G.
Lainas, T.
Bosdou, J.
Chatzimeletiou, A.
Grimbizis, G.
Kolibianakis, E.
HUMAN REPRODUCTION, 2019, 34 : 418 - 419
[4] GnRH agonist for triggering final oocyte maturation versus IVM in patients at risk of OHSS
Gidoni, Y. S.
Raziel, A.
Friedler, S.
Strassburger, D.
Hadari, D.
Kasterstein, E.
Ben-Ami, I.
Komarovsky, D.
Maslansky, B.
Bern, O.
Ron-El, R.
HUMAN REPRODUCTION, 2013, 28 : 339 - 339
[5] Optimization of oocyte retrieval rate in women undergoing ovarian stimulation for in-vitro fertilization using hCG or GnRH agonist for triggering final oocyte maturation
Bosdou, J.
Deligeoroglou, E.
Pavlidi, O.
Makedos, A.
Mitsoli, A.
Lainas, G.
Lainas, T.
Sfontouris, I.
Malandri, M.
Tarlatzi, T.
Sabbaidou, D.
Chatzimeletiou, A.
Zepiridis, L.
Grimbizis, G.
Kolibianakis, E.
HUMAN REPRODUCTION, 2020, 35 : 1415 - 1416
[6] GnRH agonist for triggering final oocyte maturation in patients with PCO at high risk for severe OHSS: factors predicting live birth in subsequent FRET cycles
Tarlatzi, T.
Bosdou, J.
Venetis, C.
Lainas, G.
Sfontouris, I.
Makedos, A.
Chatzimeletiou, K.
Zepiridis, L.
Mitsoli, A.
Savaidou, D.
Lainas, T.
Tarlatzis, B.
Kolibianakis, E.
HUMAN REPRODUCTION, 2016, 31 : 129 - 130
[7] GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?
S. Kol
I. Solt
Journal of Assisted Reproduction and Genetics, 2008, 25 : 63 - 66
[8] GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?
Kol, S.
Solt, I.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2008, 25 (2-3) : 63 - 66
[9] Triggering of final oocyte maturation with GnRH agonist in patients with polycystic ovaries undergoing IVF
Makedos, A.
Kolibianakis, E. M.
Venetis, C. A.
Masouridou, S.
Chatzimeletiou, K.
Zepiridis, L.
Mitsoli, A.
Lainas, G.
Sfontouris, I.
Tzamtzoglou, A.
Kyrou, D.
Lainas, T.
Tarlatzis, B. C.
HUMAN REPRODUCTION, 2013, 28 : 348 - 348
[10] TRIGGERING FINAL OOCYTE MATURATION WITH GNRH AGONIST IN PATIENTS WITH POLYCYSTIC OVARIES UNDERGOING IVF
Kolibianakis, E. M.
Kyrou, D.
Venetis, C. A.
Sfontouris, I.
Lainas, T. G.
Tarlatzis, B. C.
FERTILITY AND STERILITY, 2012, 98 (03) : S259 - S259

← 1 2 3 4 5 →